Cargando…
Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
Efficient drug accumulation in tumor is essential for chemotherapy. We developed redox-responsive diselenide-based high-loading prodrug nanoparticles (NPs) for targeted triple negative breast cancer (TNBC) treatment. Method: Redox-responsive diselenide bond (Se-Se) containing dimeric prodrug (PTXD-S...
Autores principales: | He, Xi, Zhang, Jinxiao, Li, Chao, Zhang, Yu, Lu, Yifei, Zhang, Yujie, Liu, Lisha, Ruan, Chunhui, Chen, Qinjun, Chen, Xinli, Guo, Qin, Sun, Tao, Cheng, Jianjun, Jiang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217054/ https://www.ncbi.nlm.nih.gov/pubmed/30429875 http://dx.doi.org/10.7150/thno.27581 |
Ejemplares similares
-
Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
por: Ruan, Chunhui, et al.
Publicado: (2018) -
Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy
por: He, Xi, et al.
Publicado: (2018) -
Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
por: Guise, Christopher P., et al.
Publicado: (2014) -
Antibody-Based Imaging of Bioreductive Prodrug Release
in Hypoxia
por: Tosun, Çağla, et al.
Publicado: (2023) -
Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity
por: Liu, Lisha, et al.
Publicado: (2018)